
AKUMS
NSEPrice History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Trend
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Price Action
Support & Resistance Levels
Volume Analysis
Stop Loss Levels
Fixed Risk
Technical Levels
Moving Averages
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹1,008.5 Cr | ₹1,024 Cr | ₹1,017.5 Cr | ₹1,159.6 Cr |
| Net Profit | ₹147.6 Cr | ₹63.5 Cr | ₹40.8 Cr | ₹66.3 Cr |
| EPS | — | ₹4.15 | ₹2.66 | ₹4.33 |
| Operating Profit | ₹115.5 Cr | ₹150.8 Cr | ₹123.4 Cr | ₹163 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for AKUMS
View All
Stock market rally: Aegis Logistics, Cupid, Akums Drugs, JB Chemicals, among 47 stocks that hit 52-week high on NSE - Upstox
Stock market rally: Aegis Logistics, Cupid, Akums Drugs, JB Chemicals, among 47 stocks that hit 52-week high on NSEUpstox
Market Trading Guide: Akums Drugs among 4 stock recommendations for Thursday
Domestic equities ended lower amid global uncertainty and caution ahead of key US inflation data. Despite market weakness, analysts remain bullish on Akums Drugs and Aditya Birla Sun Life AMC after strong technical breakouts, rising volumes and improving momentum indicators.

Akums Drugs, subsidiary Akumentis Healthcare face ₹134 crore Income Tax demand
Shares of Akums Drugs and Pharmaceuticals Ltd ended at ₹513.00, down by ₹6.70, or 1.29%, on the BSE.